DE5-14112-66278
2 vaccinations
1 coded response
27 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 393 / MS
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-05
Registered in v-safe
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-05
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2021-03-08
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-06-03
-
2021-09-02
Survey response — 6 months, dose 1MedDRA: Bronchitis, Postpartum state, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Bronchitis, preeclampsia, postpartum preeclampsiaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-02
Report sent to call center — 6 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-03
-
2021-11-01
Dose 2 — Pfizer-BioNTech
- 2021-11-02
-
2021-11-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-09
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-08
- 2021-12-13
- 2022-01-31
- 2022-05-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-01 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 9 — 6 months, dose 1
Symptoms: Bronchitis, preeclampsia, postpartum preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | ✓ | · | ✓ |
| SD | Postpartum state | ✓ | · | ✓ |
| SD | Pre-eclampsia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release